Track Coloplast A/S — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Coloplast A/S COLO-B.CO · Stock Open Coloplast A/S in new tab

442.50 DKK
P/E
35.55
EPS
12.26
Yield
5.06%
P/B
7.34
ROE
18.53
Beta
0.57
Target Price
462.81 DKK
Loading chart...
Key Metrics
Earnings dateNov. 3, 2026
P/E35.55
EPS12.26
Book Value59.37
Price to Book7.34
Debt/Equity178.07
% Insiders29.795%
Growth
Revenue Growth0.06%
Earnings Growth0.82%
Estimates
Forward P/E16.76
Forward EPS26.00
Target Mean Price462.81
Dividend
Dividend Yield5.06%
Annual dividends23.00 DKK
Ex-Div. DateMay 18, 2026
Payout187.60%
5y avg Yield2.88%

DCF valuation

Model fair value for Coloplast A/S (COLO-B.CO)
Result
Sign in to run the valuation for COLO-B.CO.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
21 analysts · consensus Hold · mean target 462.81 DKK (low 377.00, high 600.00) · as of 10 Oct 2026
Low 377.00
Mean 462.81
High 600.00
Price 442.50
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Coloplast A/S Logo Coloplast A/S Analysis (COLO-B.CO)

Denmark Health Care Official Website Stock

Is Coloplast A/S a good investment? Coloplast A/S (COLO-B.CO) is currently trading at 442.50 DKK. Market analysts have a consensus price target of 462.81 DKK. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 35.55. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Coloplast A/S is expected to release its next earnings report on Nov. 3, 2026. The market consensus estimate for Forward EPS is 26.00.

For income investors, Coloplast A/S pays a dividend yield of 5.06%. With a payout ratio of 188%, the dividend appears to be under pressure.

Investor FAQ

Does Coloplast A/S pay a dividend?

Yes, it pays an annual dividend of 23.00 DKK (5.06% yield).

What asset class is Coloplast A/S?

Coloplast A/S is classified as a Stock. You can compare it against 4 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Nov. 3, 2026. The company currently has a trailing EPS of 12.26.

Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Exchange Ticker
CPH (Denmark) COLO-B.CO
PNK (United States) CLPBF
GER (Germany) CBHD.DE
FRA (Germany) CBHD.F
Trades
Dividend Yield
5.06%
5y avg 2.88%
Annual Dividends
23.00DKK
Next Ex. Div Date
May 18, 2026
Payout Ratio
187.60%
Dividend History paid per year (DKK)
Historical Dividends
Year Total Dividends
▸2027
5.00 DKK
May 10, 2027 (estimated) 5.0000
▸2026
24.25 DKK
Dec. 10, 2026 (estimated) 19.2488
May 20, 2026 5.0000
▸2025
23.00 DKK
Dec. 9, 2025 18.0000
May 12, 2025 5.0000
▸2024
22.00 DKK
Dec. 10, 2024 17.0000
May 15, 2024 5.0000
▸2023
21.00 DKK
Dec. 12, 2023 16.0000
May 17, 2023 5.0000
▸2022
20.00 DKK
Dec. 6, 2022 15.0000
May 11, 2022 5.0000
▸2021
19.00 DKK
Dec. 7, 2021 14.0000
May 12, 2021 5.0000
▸2020
18.00 DKK
Dec. 8, 2020 13.0000
May 13, 2020 5.0000
▸2019
17.00 DKK
Dec. 10, 2019 12.0000
May 8, 2019 5.0000
▸2018
16.00 DKK
Dec. 10, 2018 11.0000
May 9, 2018 5.0000
▸2017
15.00 DKK
Dec. 12, 2017 10.5000
May 10, 2017 4.5000
▸2016
13.50 DKK
Dec. 6, 2016 9.0000
May 9, 2016 4.5000
▸2015
12.50 DKK
Dec. 10, 2015 8.0000
May 7, 2015 4.5000
▸2014
12.00 DKK
Dec. 5, 2014 7.5000
May 9, 2014 4.5000
▸2013
10.00 DKK
Dec. 6, 2013 7.0000
May 6, 2013 3.0000
▸2012
20.00 DKK
Dec. 12, 2012 20.0000
▸2011
14.00 DKK
Dec. 8, 2011 14.0000
▸2010
10.00 DKK
Dec. 2, 2010 10.0000
▸2009
7.00 DKK
Dec. 2, 2009 7.0000
▸2008
6.00 DKK
Dec. 18, 2008 6.0000
▸2007
9.00 DKK
Dec. 19, 2007 9.0000
▸2006
4.00 DKK
Dec. 14, 2006 4.0000
▸2005
3.50 DKK
Dec. 15, 2005 3.5000
▸2004
6.00 DKK
Dec. 10, 2004 6.0000
▸2003
5.00 DKK
Dec. 17, 2003 5.0000
▸2002
4.35 DKK
Dec. 17, 2002 4.3500
▸2001
3.60 DKK
Dec. 19, 2001 3.6000
▸2000
3.00 DKK
Dec. 14, 2000 3.0000
Upcoming Dividends
Name Payment Date Status Amount
Coloplast A/S May 20, 2026 5.0 DKK
Coloplast A/S Dec 09, 2025 18.0 DKK
Stock Splits
Split Date Split Ratio to 1
Jan. 19, 2000 2:1
Dec. 16, 2004 2:1
Dec. 19, 2012 5:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion